BIIB vs OLN · P/E 21, rev $9.89B vs rev $6.54B
Biogen Inc (BIIB) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. OLN currently screens at market cap $2.62B.
Not investment advice. Open the BIIB and OLN stock pages for the full models.
Not investment advice.